000 01152 a2200325 4500
005 20250516133322.0
264 0 _c20130723
008 201307s 0 0 eng d
022 _a1537-4513
024 7 _a10.1097/CJI.0b013e3182829747
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrichard, Vincent G
245 0 0 _aCancer regression and neurological toxicity cases after anti-MAGE-A3 TCR gene therapy.
_h[electronic resource]
260 _bJournal of immunotherapy (Hagerstown, Md. : 1997)
_cFeb 2013
300 _a79-81 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAntigens, Neoplasm
650 0 4 _aFemale
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aMale
650 0 4 _aMelanoma
_xtherapy
650 0 4 _aNeoplasm Proteins
650 0 4 _aReceptors, Antigen, T-Cell
700 1 _aLouahed, Jamila
700 1 _aClay, Timothy M
773 0 _tJournal of immunotherapy (Hagerstown, Md. : 1997)
_gvol. 36
_gno. 2
_gp. 79-81
856 4 0 _uhttps://doi.org/10.1097/CJI.0b013e3182829747
_zAvailable from publisher's website
999 _c22473950
_d22473950